IDENTIFYING FACTORS WHICH INFLUENCE THE SELECTION OF ANTI-TNF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ENGLAND

被引：1
|
作者：
Gavan, S. [1 ]
Harrison, M. [2 ]
Barton, A. [1 ]
Hyrich, K. [1 ]
Isaacs, J. [3 ]
Morgan, A. [4 ]
Wilson, A. G. [5 ]
Payne, K. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Univ Coll Dublin, Dublin, Ireland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1106
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS76
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [21] Anti-TNF agents for rheumatoid arthritis
    Seymour, HE
    Worsley, A
    Smith, JM
    Thomas, SHL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 201 - 208
  • [22] Long-term effect of anti-TNF treatment on atherosclerosis risk factors in rheumatoid arthritis patients
    Sayo, Yoshitaka
    Dobashi, Hiroaki
    Matsubara, Shur
    Tada, Satoshi
    Taminato, Tomohiko
    Ishiija, Toshihiko
    DIABETES, 2008, 57 : A601 - A601
  • [23] Anti-TNF therapy in rheumatoid arthritis
    Meyer, O
    PRESSE MEDICALE, 2000, 29 (09): : 463 - 468
  • [24] Anti-TNF in rheumatoid arthritis: an overview
    Radner, Helga
    Aletaha, Daniel
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2015, 165 (1-2) : 3 - 9
  • [25] Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
    Cuchacovich, Miguel
    Bueno, Daniel
    Carvajal, Rodrigo
    Bravo, Nicolas
    Carlos Aguillon, Juan
    Catalan, Diego
    Soto, Lilian
    CLINICAL RHEUMATOLOGY, 2014, 33 (12) : 1707 - 1714
  • [26] Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
    Miguel Cuchacovich
    Daniel Bueno
    Rodrigo Carvajal
    Nicolás Bravo
    Juan Carlos Aguillón
    Diego Catalán
    Lilian Soto
    Clinical Rheumatology, 2014, 33 : 1707 - 1714
  • [27] Long-term effect of anti-TNF treatment on atherosclerosis risk factors in rheumatoid arthritis patients
    Sayo, Y.
    Dobashi, H.
    Matsubara, S.
    Ishida, I.
    DIABETOLOGIA, 2008, 51 : S538 - S538
  • [28] Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
    Emery, Paul
    RHEUMATOLOGY, 2012, 51 : V22 - V30
  • [29] HLA-DRB1 influence on anti-TNF treatment in British Caucasian rheumatoid arthritis patients
    Harrison, P.
    Pointon, J. J.
    Farrar, C.
    Ziel, V.
    Harin, A.
    Jess, C.
    Brown, M. A.
    Wordsworth, B. P.
    RHEUMATOLOGY, 2006, 45 : I50 - I50
  • [30] Influence of age on the outcome of anti-TNFα therapy in rheumatoid arthritis
    Radovits, Beata J.
    Kievit, Wietske
    Fransen, Jaap
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    van Riel, Piet L. C. M.
    Laan, Roland F. J. M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S765 - S765
12345